ArticleAnnals of medicine2026

Plasma proteome profiling identifies XPNPEP3 as a novel biomarker associated with metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus.

Hua Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.